Medical use of tafoxiparin
US12419904B2 · kind B2 · utility
0Cited by
0References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2025 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Feb 4, 2045 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to tafoxiparin for use in the spontaneous onset of labor in a term pregnant woman, wherein tafoxiparin is administered in a daily dose of 30-320 mg per day.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.